New Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25210 | MAT2A-IN-23 | 2925324-58-7 | ≧98.0% |  |
| MAT2A-IN-23 39 is a potent MTA2A inhibitor. | ||||
| 26A001 | Enterololin | 1445830-39-6 | ≧98.0% |  |
| Enterololin is an antibacterial compound with targeted activity against Enterobacteri | ||||
| 26A002 | Quecitinib | 2416858-84-7 | ≧98.0% |  |
| Quecitinib is a dual inhibitor of JAK1 and TYK2. | ||||
| 26A003 | Pimicotinib hydrochloride | 2759304-23-7 | ≧98.0% |  |
| Pimicotinib (ABSK021) hydrochloride is a selective and orally active CSF1R inhibitor. | ||||
| 26A012 | GLO1 inhibitor-Compound 60 | 2314467-61-1 | ≧98.0% |  |
| GLO1 inhibitor-Compound 60 is a novel potent Glyoxalase 1 (GLO1) inhibitor. | ||||
| 26A016 | iMQT_020 | 2463893-46-9 | ≧98.0% |  |
| iMQT_020 is a specific small molecule inhibitor targeting mitochondrial SLC1A5_var (a | ||||
| 26A004 | Atumelnant ( CRN-04894 ) | 2392970-97-5 | ≧98.0% | _2392970-97-5.png) |
| Atumelnant ( CRN-04894 ) is the first investigational once-daily, oral melanocortin t | ||||
| 26A005 | EDI-048 | 2767264-57-1 | ≧98.0% |  |
| EDI048 is a Cryptosporidium PI(4)K inhibitor. | ||||
| 26A006 | Calderasib ( MK-1084 ) | 2641216-67-1 | ≧98.0% | .png) |
| Calderasib (MK-1084) is an orally available inhibitor of the oncogenic KRAS substitut | ||||
| 26A007 | Ofirnoflast | 2731294-23-6 | ≧98.0% | _2731294-23-6.png) |
| Ofirnoflast is a first-in-class, orally bioavailable NEK7 inhibitor. | ||||
| 26A008 | Soficitinib | 2574524-67-5 | ≧98.0% |  |
| Soficitinibis a small-molecule inhibitor of non-receptor tyrosine-protein kinase (TYK | ||||
| 26A009 | Velzatinib (IDRX-42, M-4205) | 2590556-80-0 | ≧98.0% |  |
| Velzatinib is an orally bioavailable small molecule inhibitor of multiple mutated for | ||||